CannaPharmaRX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0	0	0	0	0	0.03
Cash & Short-Term Investments	0	0	0	0	0	0.03
Cash Growth	-47.60%	-16.33%	231.69%	-71.95%	-91.66%	-91.71%
Accounts Receivable	0.01	0.16	0	-	-	-
Other Receivables	0.02	0.03	0.02	0.06	0.02	0
Receivables	0.03	0.19	0.02	0.06	0.02	0
Inventory	0.9	1.12	1	1.13	-	-
Prepaid Expenses	-	-	-	-	0.07	-
Other Current Assets	-	-	-	-	0.01	-
Total Current Assets	0.93	1.31	1.02	1.2	0.1	0.03
Property, Plant & Equipment	5.65	5.71	5.3	6.03	6.16	0.01
Long-Term Investments	-	-	4.52	4.52	0.08	0.08
Total Assets	6.58	7.02	10.84	11.75	6.34	0.11
Accounts Payable	10.23	5.47	4.78	4.93	6.92	3.13
Accrued Expenses	2.59	6.42	6.8	4.38	0.3	0.19
Short-Term Debt	1.02	1.19	4.01	6.68	1.22	0.8
Current Portion of Long-Term Debt	13.61	12.88	4.43	0.33	7.72	8.22
Current Portion of Leases	0.98	1	0.73	0.75	0.26	-
Current Unearned Revenue	-	0.26	-	-	-	-
Other Current Liabilities	3.06	4.37	5	1.66	1.93	0.7
Total Current Liabilities	31.49	31.59	25.75	18.73	18.35	13.04
Long-Term Debt	0.43	0.55	-	-	-	-
Long-Term Leases	4.93	5.03	4.89	5.17	5.33	-
Other Long-Term Liabilities	-	-	-	-	-	-0
Total Liabilities	36.85	37.17	30.65	23.9	23.68	13.04
Common Stock	0.07	0.07	0.07	0.04	0.03	0.01
Additional Paid-In Capital	81.52	81.52	80.12	76.48	74.8	73.06
Retained Earnings	-112.7	-112.32	-101.18	-91.28	-94.97	-86.16
Treasury Stock	-	-	-	-	-0	-0
Comprehensive Income & Other	0.21	-0.05	0.56	-0.03	0.24	-0.37
Total Common Equity	-30.9	-30.78	-20.44	-14.79	-19.9	-13.47
Shareholders' Equity	-30.27	-30.15	-19.81	-12.15	-17.34	-12.93
Total Liabilities & Equity	6.58	7.02	10.84	11.75	6.34	0.11
Total Debt	20.97	20.65	14.06	12.94	14.52	9.02
Net Cash (Debt)	-20.97	-20.65	-14.06	-12.93	-14.52	-8.99
Net Cash Per Share	-0.03	-0.03	-0.02	-0.04	-0.07	-0.12
Filing Date Shares Outstanding	678.5	672.27	656.27	656.27	298.85	166.45
Total Common Shares Outstanding	678.5	656.27	656.27	434.52	273.99	125.38
Working Capital	-30.56	-30.28	-24.73	-17.53	-18.25	-13.01
Book Value Per Share	-0.05	-0.05	-0.03	-0.03	-0.07	-0.11
Tangible Book Value	-30.9	-30.78	-20.44	-14.79	-19.9	-13.47
Tangible Book Value Per Share	-0.05	-0.05	-0.03	-0.03	-0.07	-0.11
Machinery	-	-	-	0.21	0.13	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.